In addition, blocking CD155 on gastric cancer cells effectively controlled tumor growth, reduced tumor glucose metabolism, and enhanced the metabolism of nutritionally competitive CD8+ T cells and the immune response [47]. This evidence concerns the gene CD8A and neoplasm.